1. Home
  2. CVGI vs CNTB Comparison

CVGI vs CNTB Comparison

Compare CVGI & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$4.51

Market Cap

167.7M

ML Signal

HOLD

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$2.44

Market Cap

135.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGI
CNTB
Founded
2000
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.7M
135.7M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
CVGI
CNTB
Price
$4.51
$2.44
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
657.7K
451.1K
Earning Date
05-05-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
316.18
N/A
EPS
0.04
N/A
Revenue
$755,231,000.00
$64,000.00
Revenue This Year
$4.84
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
$110.00
N/A
Revenue Growth
14.06
N/A
52 Week Low
$1.29
$1.23
52 Week High
$5.88
$3.82

Technical Indicators

Market Signals
Indicator
CVGI
CNTB
Relative Strength Index (RSI) 41.13 61.59
Support Level $3.73 $2.30
Resistance Level $4.45 $2.68
Average True Range (ATR) 0.40 0.18
MACD -0.07 0.06
Stochastic Oscillator 8.15 91.53

Price Performance

Historical Comparison
CVGI
CNTB

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: